* Nutex Health Inc NUTX.OQ NUTX.O is expected to show a
rise
in quarterly revenue when it reports results on February 29
(estimated) for the period ending December 31 2023
* The Houston Texas-based company is expected to report a
32.9% increase in revenue to $71.4 million from $53.72 million a
year ago, according to the estimate from one analyst, based on
LSEG data.
* LSEG's mean analyst estimate for Nutex Health Inc is for
breakeven results per share.
* The one available analyst rating on the shares is "buy".
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Nutex
Health Inc
is $1.00, above its last closing price of $0.11.
This summary was machine generated February 27 at 23:49 GMT.
All figures in US dollars unless otherwise stated. (For
questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)